Alzheimer's Disease

Joe Walsh is the first Alzheimer's patient to be treated with an experimental nasal spray designed to reduce inflammation in the brain.

The first Alzheimer's blood test cleared by the Food And Drug Administration is poised to change the way doctors diagnose and treat the disease.

The Tulsa Opera partnered with a national program called Songs By Heart to bring interactive music therapy to the memory care community.

Researchers found diagnosis rates varied depending on location — with parts of the Great Plains and Southwest seeing fewer dementia cases than predicted.

A new generation of blood tests can help diagnose Alzheimer’s disease. But many doctors don’t yet know how to use them.

Early in life, the protein Reelin helps assemble the brain. Later on, it appears to protect the organ from Alzheimer's and other threats to memory and thinking.

Advisers to the Food and Drug Administration have recommended unanimously that the agency approve the Alzheimer’s drug donanemab.

A new generation of blood tests can help doctors diagnose Alzheimer's without a brain scan or spinal tap. But only a few perform as well as traditional tests.

Biomarker testing is a tool that doctors use to get a clearer picture of a medical problem — often cancer.

The experimental drug lecanemab was able to slow down Alzheimer's in a large study. Many researchers think the drug will become the first to help large numbers of patients.